Image

Irinotecan Liposome in Combination With Capecitabine

Investigating Irinotecan Liposome with Capecitabine for Advanced Pancreatic Cancer

Recruiting
18-80 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the use of irinotecan liposome in combination with capecitabine for patients with pancreatic cancer.

The purpose of this study is to evaluate the effectiveness and safety of this combination therapy as a second-line treatment. It seeks to provide more options for patients who have not responded to previous treatments.

  • Who can participate: Participants must be between 18 and 80 years old with confirmed unresectable or metastatic pancreatic cancer. They should have experienced tumor progression after prior treatment and meet specific health criteria, including a certain level of physical fitness and organ function.
  • Study details: Participants will receive a regimen of irinotecan liposome combined with capecitabine. A placebo is not used in this study. The focus is on monitoring safety and effectiveness throughout the treatment period.
Print
Study details
    Pancreatic Cancer

NCT06578052

Junjie Hang

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.